Integral Diagnostics Ltd. (AU:IDX) has released an update.
Integral Diagnostics Limited has announced the cessation of 15,352 options due to their expiry without exercise or conversion, as of August 7, 2024. This development may influence the company’s stock market performance, and is of interest to investors monitoring the company’s capital structure changes.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.
